Xgeva (denosumab, AMG 162; Human Monoclonal Antibody to RANK Ligand)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
WARNINGS AND PRECAUTIONS
Hypercalcemia Following Treatment Discontinuation in Patients with Growing Skeletons
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts